The University of Southampton
University of Southampton Institutional Repository

Uva-ursi exract and ibuprofen as alternative treatments of adult female urinary tract infection (ATAFUTI): study protocol for a randomised controlled trial

Uva-ursi exract and ibuprofen as alternative treatments of adult female urinary tract infection (ATAFUTI): study protocol for a randomised controlled trial
Uva-ursi exract and ibuprofen as alternative treatments of adult female urinary tract infection (ATAFUTI): study protocol for a randomised controlled trial
Background

Women with acute uncomplicated urine infection are usually treated with antibiotics. One trial has demonstrated that delayed antibiotic treatment offered without symptom relief results in a modest reduction in antibiotic use. There is some evidence that ibuprofen provides symptom relief and reduces antibiotic use. Uva-ursi, a herbal product, has a traditional use for urinary infection symptom relief. We set out to test: in adult women with suspected UTI who accept the delayed prescription strategy: Do NSAIDs or uva-ursi (a herbal product) provide relief from urinary symptoms and reduce antibiotic use.

Methods/design

Adult women with suspected urinary tract infection presenting to primary care will be randomised using a factorial trial design in which patients will be randomised to one of two interventions as below:

• Group 1 – Uva-ursi + advice to take ibuprofen

• Group 2 – Placebo + advice to take ibuprofen

• Group 3 – Uva-ursi + no advice to take ibuprofen

• Group 4 – Placebo + no advice to take ibuprofen

Patients and physicians will be blinded to the randomised group for the herb.

The main outcome is symptom severity at days 2–4 recorded in a validated, self-report diary used in previous studies.

Secondary outcomes include antibiotic use and symptom duration.

In total the trial will require 328 patients in order to achieve at least 90% power for the primary endpoint and 80% for the secondary endpoint.

In accordance with CONSORT guidelines all comparative analyses will be conducted on an intention-to-treat basis using SPSS or similar package.

Discussion

The outcomes from this trial have the potential to modify the current approach to the management of acute urinary symptoms with less dependence on the use of antibiotics.

Trial registration

ISRCTN registry, ID: ISRCTN43397016. Registered on 11 February 2015.
1745-6215
1-9
Trill, Jeanne
65ee5141-abbb-4389-9bd1-5da6199a26cb
Simpson, Catherine
60c008cf-9ba0-4c41-815c-ad66a04aaed2
Webley, Frances
143f965b-866b-4455-89a5-d187f52e1cde
Radford, Michael
72cf921a-9179-430e-80d0-9970ae4099bb
Stanton, Louise
8b827763-d839-4b4b-bbf2-358a84110294
Maishman, Thomas
cf4259a4-0eef-4975-9c9d-a2c3d594f989
Galanopoulou, Angeliki
a7a4ffa6-e854-49ef-b55c-994ec2ee751d
Flower, Andrew
5256a2c8-6e74-49be-acc8-463ed3c18c6a
Eyles, Caroline
f8518cbb-669f-4cf6-bacb-4a174e385483
Willcox, Merlin
dad5b622-9ac2-417d-9b2e-aad41b64ffea
Hay, Alastair
daf3c71f-5e5a-4bee-9bb8-7df67ec2a79f
Griffiths, Gareth
7fd300c0-d279-4ff6-842d-aa1f2b9b864d
Little, Paul
1bf2d1f7-200c-47a5-ab16-fe5a8756a777
Lewith, George
0fc483fa-f17b-47c5-94d9-5c15e65a7625
Moore, Michael
1be81dad-7120-45f0-bbed-f3b0cc0cfe99
Trill, Jeanne
65ee5141-abbb-4389-9bd1-5da6199a26cb
Simpson, Catherine
60c008cf-9ba0-4c41-815c-ad66a04aaed2
Webley, Frances
143f965b-866b-4455-89a5-d187f52e1cde
Radford, Michael
72cf921a-9179-430e-80d0-9970ae4099bb
Stanton, Louise
8b827763-d839-4b4b-bbf2-358a84110294
Maishman, Thomas
cf4259a4-0eef-4975-9c9d-a2c3d594f989
Galanopoulou, Angeliki
a7a4ffa6-e854-49ef-b55c-994ec2ee751d
Flower, Andrew
5256a2c8-6e74-49be-acc8-463ed3c18c6a
Eyles, Caroline
f8518cbb-669f-4cf6-bacb-4a174e385483
Willcox, Merlin
dad5b622-9ac2-417d-9b2e-aad41b64ffea
Hay, Alastair
daf3c71f-5e5a-4bee-9bb8-7df67ec2a79f
Griffiths, Gareth
7fd300c0-d279-4ff6-842d-aa1f2b9b864d
Little, Paul
1bf2d1f7-200c-47a5-ab16-fe5a8756a777
Lewith, George
0fc483fa-f17b-47c5-94d9-5c15e65a7625
Moore, Michael
1be81dad-7120-45f0-bbed-f3b0cc0cfe99

Trill, Jeanne, Simpson, Catherine, Webley, Frances, Radford, Michael, Stanton, Louise, Maishman, Thomas, Galanopoulou, Angeliki, Flower, Andrew, Eyles, Caroline, Willcox, Merlin, Hay, Alastair, Griffiths, Gareth, Little, Paul, Lewith, George and Moore, Michael (2017) Uva-ursi exract and ibuprofen as alternative treatments of adult female urinary tract infection (ATAFUTI): study protocol for a randomised controlled trial. Trials, 18 (421), 1-9. (doi:10.1186/s13063-017-2145-7).

Record type: Article

Abstract

Background

Women with acute uncomplicated urine infection are usually treated with antibiotics. One trial has demonstrated that delayed antibiotic treatment offered without symptom relief results in a modest reduction in antibiotic use. There is some evidence that ibuprofen provides symptom relief and reduces antibiotic use. Uva-ursi, a herbal product, has a traditional use for urinary infection symptom relief. We set out to test: in adult women with suspected UTI who accept the delayed prescription strategy: Do NSAIDs or uva-ursi (a herbal product) provide relief from urinary symptoms and reduce antibiotic use.

Methods/design

Adult women with suspected urinary tract infection presenting to primary care will be randomised using a factorial trial design in which patients will be randomised to one of two interventions as below:

• Group 1 – Uva-ursi + advice to take ibuprofen

• Group 2 – Placebo + advice to take ibuprofen

• Group 3 – Uva-ursi + no advice to take ibuprofen

• Group 4 – Placebo + no advice to take ibuprofen

Patients and physicians will be blinded to the randomised group for the herb.

The main outcome is symptom severity at days 2–4 recorded in a validated, self-report diary used in previous studies.

Secondary outcomes include antibiotic use and symptom duration.

In total the trial will require 328 patients in order to achieve at least 90% power for the primary endpoint and 80% for the secondary endpoint.

In accordance with CONSORT guidelines all comparative analyses will be conducted on an intention-to-treat basis using SPSS or similar package.

Discussion

The outcomes from this trial have the potential to modify the current approach to the management of acute urinary symptoms with less dependence on the use of antibiotics.

Trial registration

ISRCTN registry, ID: ISRCTN43397016. Registered on 11 February 2015.

Text
s13063-017-2145-7 - Version of Record
Available under License Creative Commons Attribution.
Download (1MB)

More information

Accepted/In Press date: 14 August 2017
e-pub ahead of print date: 8 September 2017

Identifiers

Local EPrints ID: 414498
URI: http://eprints.soton.ac.uk/id/eprint/414498
ISSN: 1745-6215
PURE UUID: d582b3a3-8bd5-4d49-aa0b-fe32de29d7e7
ORCID for Louise Stanton: ORCID iD orcid.org/0000-0001-8181-840X
ORCID for Merlin Willcox: ORCID iD orcid.org/0000-0002-5227-3444
ORCID for Gareth Griffiths: ORCID iD orcid.org/0000-0002-9579-8021
ORCID for Michael Moore: ORCID iD orcid.org/0000-0002-5127-4509

Catalogue record

Date deposited: 03 Oct 2017 16:31
Last modified: 16 Mar 2024 04:28

Export record

Altmetrics

Contributors

Author: Jeanne Trill
Author: Catherine Simpson
Author: Frances Webley
Author: Michael Radford
Author: Louise Stanton ORCID iD
Author: Thomas Maishman
Author: Angeliki Galanopoulou
Author: Andrew Flower
Author: Caroline Eyles
Author: Merlin Willcox ORCID iD
Author: Alastair Hay
Author: Paul Little
Author: George Lewith
Author: Michael Moore ORCID iD

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×